Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5698161 | Clinical Oncology | 2016 | 7 Pages |
Abstract
Once-weekly 3D-CRT leads to excellent biochemical disease-free survival and acceptable toxicities. Pre-treatment EPIC sexual function dropped by 42% at 5 years of follow-up. This functional deficit did not bother patients, possibly due to the already low sexual function at baseline.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
M. Zimmermann, D. Taussky, C. Menkarios, Ã. Vigneault, M.-C. Beauchemin, J.-P. Bahary, A.-A.-G. Martin, L.-V. Diaz de Bedoya, C. Lambert,